MedTrace Logo

Analysis of Sublingual Glycocalyx Damage at ICU Admission to Predict Risk of Death

NCT03847493 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-11-07

No results posted yet for this study

Summary

The aim of this observative, prospective study is to evaluate if and to what extent glycocalyx damage/microcirculation data at admission in the ICU as well as during ICU stay can be predictive of mortality and clinical course in patients presenting with the suspicion of sepsis/septic shock. Therefore, the enrollment of ca 100 ICU patients is planned.

Conditions

  • Sepsis
  • Septic Shock
  • Endothelial Dysfunction

Interventions

OTHER

Endothelial Glycocalyx

Non-invasive assessment of endothelial glycocalyx dimensions.

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Philipp Kümpers, MD · University Hospital Muenster

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2022-12-30
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847493 on ClinicalTrials.gov